Jubilant Pharmova
NSE: JUBLPHARMA
Healthcare
₹877.005.950.68%(1D)
Performance Stats for Jubilant Pharmova
Day Range
Low: ₹867.20
High: ₹891.00
52 Week Range
Low: ₹786.05
High: ₹1184.80
Open Price
868.00Previous Close
871.05Volume
229192.00Open Price
868.00Previous Close
871.05Volume
229192.00Fundamentals of Jubilant Pharmova
ROCE
1.79%
EPS
₹1.98
Dividend Yield
0.61%
P/E Ratio
205.65
P/B Ratio
5.61
Debt to Equity
0.08
Current Ratio
1.2
Sales Growth
14.11%
Profit Growth
83.81%
EBIT Growth
15.09%
Financials of Jubilant Pharmova
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Jubilant Pharmova
About Jubilant Pharmova
Jubilant Pharmova Limited was initially incorporated as Vam Organic Chemicals Limited on June 21, 1978. Company name was changed to Jubliant Organosys Limited in November, 2001 and was again changed to Jubilant Life Sciences Limited in October, 2009 ...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarey Drugs And Pharm | ₹78.1 3.09% |
| Aarti Drugs | ₹418 0.78% |
| Aarti Pharmalabs | ₹817 1.48% |
| Abbott India | ₹26250 0.5% |
Most Viewed Stocks
Sorry, option data not Found For this Stock :(
Events Related to Jubilant Pharmova
AGM
Aug 26, 2026
Board Meeting
Aug 10, 2026
Dividend
Jul 24, 2026
Board Meeting
May 22, 2026
Board Meeting
Feb 6, 2026
News About Jubilant Pharmova
Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoY
Aug 11, 2026
Jubilant Pharmova among 4 stocks flashing bullish signals, hinting at a possible uptrend
Aug 11, 2026
Avenue Supermarts among 4 stocks showing bullish RSI upswing
Aug 11, 2026
Sun Pharma, Cipla Among Systematix"s Top Pharma Picks Ahead Of Q1 Results — Full List Inside
Jul 8, 2026
Jubilant Pharmova Gets "Buy" Rating From Systematix After Inline Q3 Revenue Growth — Check Revised Target Price
Feb 9, 2026
